Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Alpharadin
Alpharadin
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Bayer predicts blockbuster success for four of its late-stage drugs
Fierce Biotech
Tue, 12/20/11 - 11:24 am
Bayer
Xarelto
VEGF Trap-Eye
regorafenib
Alpharadin
Bayer Drug Hailed As Prostate Cancer Game Changer
TheStreet.com
Mon, 09/26/11 - 11:39 am
Bayer
prostate cancer
Algeta
Amgen
Xgeva
Exelixis
Alpharadin
First Phase III trial of an alpha-pharmaceutical
eurekalert.org
Sat, 09/24/11 - 01:26 pm
Bone metastases
prostate cancer
Alpharadin
Algeta
Bayer
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bloomberg
Thu, 09/3/09 - 08:46 am
Bayer
Algeta
Alpharadin
prostate cancer